LOADING
Comparing AbbVie Inc (ABBV) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $354.6B | $152.4B |
| P/E Ratio | 84.6 | 19.7 |
| Forward P/E | 14.2 | 9.3 |
| PEG Ratio | 0.47 | 13.77 |
| EPS | $2.37 | $1.36 |
| Revenue Growth (YoY) | 10.0% | -1.2% |
| Profit Margin | 6.9% | 12.4% |
| Return on Equity | 62.3% | 8.9% |
| Dividend Yield | 3.24% | 6.30% |
| Beta | 0.36 | 0.39 |
| 52-Week High | $239.13 | $28.75 |
| 52-Week Low | $171.00 | $20.87 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.